PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
10-Jul-2024 Uni-Bio Science And Chongqing Minji Establish Strategic Partnership, Targeting Hundreds Of Billions Of Yuan of Medical Aesthetics Device Market UNI-BIO SCIENCE GROUP LIMITED
10-Jul-2024 Marcel Imwinkelried appointed as new CEO Siegfried AG
09-Jul-2024 StageZero Life Sciences Announces Update on Filing of Full Year 2023 Financials Under the Failure To File Cease Trade Order AccessWire
09-Jul-2024 MyMenopauseRx Expands to 13 States, Offering Virtual Menopause Care Nationwide AccessWire
09-Jul-2024 Cann American Corp. Provides Shareholder Update AccessWire
09-Jul-2024 Cosmos Health's Cana Secures Contract Manufacturing Agreement with Australia's Humacology for up to 500,000 CBD Units Annually AccessWire
09-Jul-2024 IMFINZI▼(DURVALUMAB) IN COMBINATION WITH CHEMOTHERAPY APPROVED IN GREAT BRITAIN FOR THE TREATMENT OF RESECTABLE NON-SMALL CELL LUNG CANCER AstraZeneca
09-Jul-2024 New Canine Study From Belhaven Biopharma Supports Dry Powder Nasal Epinephrine Delivery Solution Newswire
09-Jul-2024 New Canine Study From Belhaven Biopharma Supports Dry Powder Nasal Epinephrine Delivery Solution AccessWire
09-Jul-2024 Novel treatment improves embryo implantation and live birth rates in infertile women undergoing IVF and ICSI OXOLIFE
09-Jul-2024 Curve Therapeutics strengthens Leadership Team with appointment of experienced biotech executive Simon Jones Curve Therapeutics
09-Jul-2024 Prophylactic HIV Drugs Market Poised for Robust Growth, Expected to Reach USD 48,822.4 million by 2033 at a 4.1% of CAGR MARKITWIRED
09-Jul-2024 GenesisCare UK Strengthens Board with Appointment of Two Non-Executive Directors GenesisCare UK
09-Jul-2024 Professor Edith Heard appointed new Director and Chief Executive of the Francis Crick Institute The Francis Crick Institute
09-Jul-2024 Microbiotica to Present Positive Update on Manufacturing Progress of its Live Biotherapeutic Products for Forthcoming Melanoma and Ulcerative Colitis Clinical Studies Microbiotica
09-Jul-2024 Roche receives CE Mark for its AI-enabled continuous glucose monitoring solution offering critical predictions to people living with diabetes Roche
09-Jul-2024 iOnctura announces expansion of roginolisib clinical trial program to NSCLC iOnctura
09-Jul-2024 MIG Capital co-leads €63 million Series A round for autoimmune biotech SciRhom MIG Capital
09-Jul-2024 ABPI responds to Wes Streeting’s commitment to boosting the economy through the life sciences sector Association of the British Pharmaceutical Industry (ABPI)
09-Jul-2024 IMFINZI▼(DURVALUMAB) in combination with chemotherapy APPROVED IN GREAT BRITAIN for the treatment of resectable non-small cell lung cancer AstraZeneca